ClinConnect ClinConnect Logo
Search / Trial NCT02057783

Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension

Launched by AGIR À DOM · Feb 6, 2014

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how a specific physical activity program can help lower blood pressure in patients who have both sleep apnea and high blood pressure that doesn't respond well to standard treatments. The researchers believe that using a CPAP machine, which helps people breathe better during sleep, along with a regular exercise program, can improve blood pressure control throughout the day.

To be eligible for this trial, participants need to be between 65 and 74 years old and have obstructive sleep apnea, which is a condition where breathing repeatedly stops and starts during sleep. They also need to have high blood pressure that hasn't improved despite taking three or more medications. Participants in the trial will be asked to commit to the exercise program while using the CPAP machine. This study is currently recruiting, and it's open to everyone, regardless of gender. If you're interested in participating, it's important to know that there are some health conditions that would exclude you, such as severe liver problems or very high blood pressure at the time of screening.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient with an obstructive sleep apnea (apnea-hypopnea index \> or equal to 15)
  • Patient with resistant hypertension uncontrolled by 3 or more antihypertensive agents
  • Ambulatory patient
  • Exclusion Criteria:
  • Acute hepatic failure, biliary cirrhosis, cholestasis
  • Acute hypertension (SBP\>= 180 mmHg and/or DBP \>= 110 mmHg)
  • Contraindication to CPAP treatment

About Agir à Dom

Agir à Dom is a dedicated clinical trial sponsor focused on advancing healthcare through innovative research and development. With a commitment to improving patient outcomes, the organization specializes in conducting high-quality clinical trials across various therapeutic areas, including but not limited to chronic diseases, mental health, and geriatric care. Agir à Dom emphasizes collaboration with healthcare professionals and stakeholders to ensure the integrity and efficacy of its studies, while adhering to the highest ethical standards and regulatory requirements. Through its rigorous approach, Agir à Dom aims to contribute valuable insights to the medical community and enhance the quality of life for patients.

Locations

Lausanne, , Switzerland

Toulouse, , France

Québec, , Canada

La Tronche, , France

Genève, , Switzerland

Patients applied

0 patients applied

Trial Officials

Jean-Louis Pépin, Pr MD PhD

Principal Investigator

Laboratoire EFCR, CHU de Grenoble, 38043, Grenoble, France

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials